Divalproex Sodium

MOQ25 Kilograms/Kilograms

Medicine NameDivalproex Sodium

TypePharmaceutical Intermediates

GradeIndustrial Grade

Physical FormPowder

Product DescriptionDivalproex Sodium

MOQ500 Kilograms/Kilograms

Ph Level6.8

CAS No76584-70-8

Purity99

AppearanceWhite Powder

ApplicationPharmaceutical Industry

ColorWhite

MOQ50 Kilograms/Kilograms

FormPowder

Molecular FormulaC16H31NaO4

GradePharmaceutical Grade

FunctionAnti-epileptic

ColorWhite

Storage InstructionsStore in a cool and dry place

MOQ1000 Tablet

Drug TypeGeneric Drugs

Physical FormTablets

DosageAs per doctor

Quantity1000 Boxes

Storage InstructionsDry & Cool place

MOQ1 Piece/Pieces

Salt CompositionDivalproex ER (500mg)

Pacakaging (Quantity Per Box)10*15 Tablets

Origin of MedicineINDIA

Drug TypeGeneral Medicines

IngredientsDivalproex ER (500mg), branded as DIOWELPREX ER 500, is a medication primarily used to treat various types of seizure disorders. It also has applications in the treatment of bipolar disorder and for the prevention of migraine headaches. This extended-release formulation allows for a controlled release of the medication, ensuring steady levels in the bloodstream.How Does It Work?Mechanism of Action: Divalproex ER works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, a neurotransmitter that helps calm nervous activity.Stabilizing Electrical Activity: It helps stabilize electrical activity in the brain, preventing seizures and mood swings.Uses of Divalproex ER:Seizure Control: Effective in managing various types of seizures, including complex partial seizures and absence seizures.Bipolar Disorder: Helps stabilize mood and prevent manic episodes.Migraine Prevention: Used prophylactically to reduce the frequency and severity of migraine headaches.What is Divalproex ER?Divalproex ER is an anticonvulsant and mood stabilizer. It is the extended-release form of valproic acid, allowing for once-daily dosing, which improves patient compliance and maintains therapeutic drug levels.Side Effects:Common Side Effects: Nausea, drowsiness, dizziness, and tremors.Serious Side Effects: Liver toxicity, pancreatitis, and blood disorders.Safety Information:Regular Monitoring: Liver function tests and blood tests are recommended to monitor for potential adverse effects.Pregnancy and Breastfeeding: Should be used with caution during pregnancy and breastfeeding due to potential risks to the fetus or infant.Optimized Extended-Release FormulaDivalproex ER (500mg) features an extended-release formulation designed for gradual drug absorption. This ensures steady plasma levels, reducing the frequency of dosing and minimizing the risk of side effects, ultimately supporting consistent treatment outcomes.Reliable Indian Origin and PackagingManufactured and sourced in India, Divalproex ER tablets are carefully packaged in boxes containing a total of 150 tablets (10 strips of 15 tablets each). This bulk packaging is ideal for adult patient use, ensuring both convenience and reliable supply.Safe Storage and HandlingTo maintain the integrity of Divalproex ER, it is essential to store the tablets in a cool, dry place. Proper storage conditions help preserve the medication's effectiveness and prevent any potential degradation of the active ingredient.FAQ's of Divalproex ER (500mg):Q: How should Divalproex ER (500mg) tablets be taken for best results?A: Divalproex ER (500mg) tablets should be taken exactly as directed by your physician. Typically, the medication is administered orally, with or without food, and swallowed whole to ensure proper extended-release action.Q: What is the benefit of using the extended-release (ER) formulation of Divalproex?A: The ER formulation of Divalproex provides a consistent release of medication throughout the day, which can help in stabilizing blood levels, improving symptom management, and reducing dosing frequency for adult patients.Q: When is this medication typically recommended?A: Divalproex ER (500mg) is prescribed for adults under a physician's supervision to manage specific neurological or psychiatric conditions, such as epilepsy, bipolar disorder, or migraine prevention.Q: Where should I store Divalproex ER (500mg) tablets?A: Keep the tablets in a cool and dry place, away from moisture and direct sunlight. Proper storage will help maintain the medication's potency and effectiveness until the end of its shelf life.Q: What is the process for obtaining Divalproex ER (500mg) in India?A: Divalproex ER (500mg) is supplied and traded by authorized suppliers and traders within India. A valid prescription from a certified healthcare professional is generally required to purchase this medication.Q: How should the tablets be used to avoid adverse effects?A: Take the tablets only as prescribed by your physician and avoid altering the dosage or frequency yourself. Do not crush or split the extended-release tablets to preserve their intended effect and minimize side effects.

Physical FormTablets

MOQ100 Strip/Strips

Dosage FormTablet

Salt CompositionExtended Release tablet contains Divalproex Sodium IP Eq.to Valporic Acid 500 mg

Pacakaging (Quantity Per Box)10x10 tablet

IngredientsAzathioprine (25 mg).

Physical FormTablets

Dosage GuidelinesUse as directed by a healthcare professional

MOQ100 Unit/Units

GradeMedical Grade

FormTablet

Drug TypeGeneral Medicines

Physical FormTablets

FunctionOther

DosageAs directed by doctor.

MOQ25 Kilograms/Kilograms

Molecular Weight310.4047 Grams (g)

Molecular FormulaC16H31NaO4

StorageOther

Shelf Life5 Years

Medicine NameDivalproex Sodium

CAS No76584-70-8

MOQ1000 Box/Boxes

Drug TypeOther Types

IngredientsDivalproex Sodium

Physical FormTablets

FunctionOther

DosageAs Directed By Physician

Quantity10X10 Tablets/box Boxes

MOQ20 Kilograms/Kilograms

AppearanceWhite Powder

Purity98%

SolubilityIn water

ApplicationIndustrial

Product TypeSodium Stearoyl Lactylate

StorageRoom Temperature

MOQ15-30 Box/Boxes

Drug TypeSpecific Drug

IngredientsAlprazolam 0.25 mg & Fluoxetine 20 mg

Physical FormTablets

FunctionOther

Recommended ForEpilepsy, Migraine, Mania

DosageEpilepsy: Initial 10-15 mg/kg/day in divided dose if necessary may increase by 5-10 mg/kg/week. Migraine: 500 mg once daily for 1 week, may increase to 1000 mg once daily. Mania: Initial: 25 mg/kg once daily, Max: 60 mg/kg/day